Search Results - "SPRITZER, P. M"

Refine Results
  1. 1

    Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome by Wiltgen, D., Benedetto, I.G., Mastella, L.S., Spritzer, P.M.

    Published in Human reproduction (Oxford) (01-07-2009)
    “…BACKGROUND Metabolic disturbances are common features of polycystic ovary syndrome (PCOS), which possibly enhance the risk of cardiovascular disease. The aim…”
    Get full text
    Journal Article
  2. 2

    Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance by Mario, F M, do Amarante, F, Toscani, M K, Spritzer, P M

    “…This age-matched case-control study assessed total and segmental lean muscle mass in classic or ovulatory polycystic ovary syndrome (PCOS) patients and…”
    Get more information
    Journal Article
  3. 3

    Influence of habitual physical activity on body composition, fat distribution and metabolic variables in early postmenopausal women receiving hormonal therapy by Lara, S, Casanova, G, Spritzer, P.M

    “…Abstract Objective To determine whether there is an association between the level of habitual physical activity, body composition and anthropometric and…”
    Get full text
    Journal Article
  4. 4

    Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review by Velho, I., Fighera, T. M., Ziegelmann, P. K., Spritzer, P. M.

    Published in Andrology (Oxford) (01-09-2017)
    “…Summary Testosterone is the main hormonal agent used for cross‐sex hormone therapy in female‐to‐male transgender persons. Our aim was to systematically review…”
    Get full text
    Journal Article
  5. 5

    Nitric oxide and fibrinogen in polycystic ovary syndrome: Associations with insulin resistance and obesity by Nácul, A.P, Andrade, C.D, Schwarz, P, de Bittencourt, P.I. Homem, Spritzer, P.M

    “…Abstract Objective Nitric oxide (NO) and fibrinogen levels, two markers of vascular disease, are associated with insulin resistance, a common trait in women…”
    Get full text
    Journal Article
  6. 6

    Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men by da Silva, E. D., Spritzer, P. M., Fighera, T. M.

    “…Purpose While it is common for menstrual cycles to cease within the initial 6 months of treatment, there are instances where some transgender men may not…”
    Get full text
    Journal Article
  7. 7

    Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis by Graff, S K, Mario, F M, Ziegelmann, P, Spritzer, P M

    “…The aim of this study was to assess the effects of orlistat on weight loss-related clinical variables in overweight/obese women with polycystic ovary syndrome…”
    Get more information
    Journal Article
  8. 8

    Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment by Spritzer, P M, Motta, A B

    “…Adolescence is a time characterised by changes in reproductive hormones and menstrual patterns, which makes it difficult to diagnose polycystic ovary syndrome…”
    Get more information
    Journal Article
  9. 9

    Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study by Mario, F. M., Graff, S. K., Spritzer, P. M.

    Published in Journal of endocrinological investigation (01-04-2017)
    “…Purpose To examine the effect of habitual physical activity (PA) on the metabolic and hormonal profiles of women with polycystic ovary syndrome. Materials and…”
    Get full text
    Journal Article
  10. 10

    Androgen receptor and 5α‐reductase are expressed in pelvic endometriosis by Carneiro, MM, Morsch, DM, Camargos, AF, Reis, FM, Spritzer, PM

    “…The aim of this study was to evaluate whether androgen receptor (AR) and the enzymes that convert testosterone into the more potent androgen…”
    Get full text
    Journal Article
  11. 11

    Mediterranean diet is associated with bone mineral density and muscle mass in postmenopausal women by Silva, T. R. da, Martins, C. C., Ferreira, L. L., Spritzer, P. M.

    “…Purpose: This study aimed to investigate the association between the Mediterranean diet (MD), body composition, and bone mineral density (BMD) in…”
    Get full text
    Journal Article
  12. 12

    Dietary intake of isoflavones is associated with a lower prevalence of subclinical cardiovascular disease in postmenopausal women: cross‐sectional study by Ferreira, L. L., Silva, T. R., Maturana, M. A., Spritzer, P. M.

    Published in Journal of human nutrition and dietetics (01-12-2019)
    “…Background Menopause has been associated with an increased risk of cardiovascular disease. It has been shown that isoflavones protect vascular endothelial…”
    Get full text
    Journal Article
  13. 13

    Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements by Spritzer, P.M., Poy, M., Wiltgen, D., Mylius, L.S., Capp, E.

    Published in Human reproduction (Oxford) (01-07-2001)
    “…BACKGROUND: The known association between leptin, obesity and insulin action suggests that leptin may have a role in polycystic ovarian syndrome (PCOS) but…”
    Get full text
    Journal Article
  14. 14

    Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial by Chou, K H, von Eye Corleta, H, Capp, E, Spritzer, P M

    Published in Hormone and metabolic research (01-02-2003)
    “…There is still some controversy concerning the effects of metformin in the treatment of Polycystic Ovary Syndrome (PCOS). The aim of this study was to asses…”
    Get more information
    Journal Article
  15. 15

    Spironolactone as a single agent for long-term therapy of hirsute patients by Spritzer, Poli Mara, Lisboa, Karen O., Mattiello, Simone, Lhullier, Francisco

    Published in Clinical endocrinology (Oxford) (01-05-2000)
    “…OBJECTIVE To assess the androgen‐suppressing effect of spironolactone, and the use of this drug as a single agent in the long‐term therapy of hirsute patients…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Low-dose oral or non-oral hormone therapy: effects on C-reactive protein and atrial natriuretic peptide in menopause by Casanova, G., dos Reis, A. M., Spritzer, P. M.

    “…Abstract Objective To assess the effects of oral low-dose and non-oral hormone therapy (HT) on ultra-sensitive C-reactive protein (CRP), atrial natriuretic…”
    Get full text
    Journal Article
  18. 18

    Serotonergic 5-HT2A/2C receptors are involved in prolactin secretion in hyperestrogenic rats by Mallmann, E.S., Paixão, L., Ribeiro, M.F., Spritzer, P.M.

    Published in Neuroscience letters (17-10-2014)
    “…•Two animal models were assessed: hyperestrogenic and hypoestrogenic rats.•We tested whether estradiol modulates prolactin by acting on serotonergic…”
    Get full text
    Journal Article
  19. 19

    Estrogen receptor-α, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: Association with nodule size, hormonal and reproductive features by Cericatto, R., Pozzobon, A., Morsch, D.M., Menke, C.H., Brum, I.S., Spritzer, P.M.

    Published in Steroids (01-03-2005)
    “…Fibroadenomas are the most common benign lump in females. The study of gene alterations and/or deregulation in reproductive years may help explain hormonal…”
    Get full text
    Journal Article
  20. 20

    Association between adipose tissue expression and serum levels of leptin and adiponectin in women with polycystic ovary syndrome by Lecke, S B, Morsch, D M, Spritzer, P M

    Published in Genetics and molecular research (28-02-2013)
    “…We reviewed emerging evidence linking serum levels and adipose tissue expression of leptin and adiponectin in women with polycystic ovary syndrome (PCOS)…”
    Get full text
    Journal Article